Release Date: 31/07/13 15:34 Summary: June 2013 Quarterly Activities Report & Appendix 5B Price Sensitive: Yes Download Document 554.11KB Download
NTI Neurotech knocked back by FDA as agency declares target condition not rare enough for special status